Reply to: “Flow cytometry makes all the difference”

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Primary prevention of variceal haemorrhage: A pharmacological approach

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Mesenchymal stromal cell therapy for liver diseases

Reply to: “DCD consensus and futility in liver transplantation”

The place of downstaging for hepatocellular carcinoma

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Jordan J. Feld, Graham R. Foster Journal of Hepatology

Chronic HCV infection and the clonality of intrahepatic T cells

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Darius Moradpour, Arash Grakoui, Michael P. Manns

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Economics of chronic hepatitis B and hepatitis C

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

The use of hemospray in portal hypertensive bleeding; a case series

Volume 66, Issue 4, Pages (April 2017)

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

The relationship between age and fat infiltration in liver and muscle

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

MELD: the holy grail of organ allocation?

Volume 163, Issue 2, (October 2015)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Reply to: “Flow cytometry makes all the difference” Barbara Oliviero, Dalila Mele, Stefania Varchetta Journal of Hepatology Volume 59, Issue 4, Pages 910-911 (October 2013) DOI: 10.1016/j.jhep.2013.06.009 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Gating strategy. (A–F) Gating strategy to identify CD56dimCD16neg NK cells in a representative SVR patient. (G) No differences between the proportions of dead cells (mean±SEM) in the CD56dim/CD16neg and CD56bright or CD16pos NK subpopulations in SVR and NR patients. Journal of Hepatology 2013 59, 910-911DOI: (10.1016/j.jhep.2013.06.009) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions